Healthcare Services Recapitalizations in 2021

Acquisition Volume in Healthcare Services Recapitalizations in 2021 by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for Healthcare Services Recapitalizations in 2021. 40 2022 26 2023 18 2024 20 2025 ~16 est. 4 2026
Actual Full-year estimate
  • Buyer
    NewSpring Healthcare
    Target
    Verisma
    Seller
    NewSpring (existing investor), Blue Heron, Other legacy investors and limited partners

    NewSpring Healthcare led a GP-led secondary recapitalization of Verisma on December 22, 2021, providing liquidity to existing investors (including Blue Heron) and admitting new investors via a continuation vehicle. The transaction injects growth capital to accelerate Verisma's healthcare disclosure management technology and platform while Verisma's management team and board remain largely in place.

  • Buyer
    Cinven, Cobepa S.A.
    Target
    BioAgilytix
    Seller
    GHO Capital Partners (GHO Capital)

    International private equity firm Cinven has agreed to acquire a majority stake in BioAgilytix through a recapitalization, with current investor Cobepa remaining a significant minority investor. GHO Capital has realised its investment and will exit; the transaction will provide funding to support BioAgilytix’s international expansion, capacity and capability investments, and buy-and-build strategy in large-molecule bioanalytical services. BioAgilytix is headquartered in Durham, North Carolina and employs about 870 staff across the United States, Europe and Australia.

  • Buyer
    Interlang, Inc. d/b/a Montgomery DME, Monument MicroCap Partners, LLC
    Target
    Premier Medical Equipment & Supply

    On December 16, 2021, Interlang, Inc. d/b/a Montgomery DME (a portfolio company of Monument MicroCap Partners) recapitalized Premier Medical Equipment & Supply. Premier, based in Colton, California, provides durable medical and home medical equipment rentals to hospice and home health providers in San Bernardino County and other parts of Southern California; the transaction expands MDME's geographic footprint and resources.

  • Buyer
    Seaside Equity Partners
    Target
    Cascade Healthcare Services
    Seller
    Evolution Capital Partners

    Seaside Equity Partners completed a majority recapitalization of Cascade Healthcare Services in December 2021, acquiring the company from majority owner Evolution Capital Partners. Cascade, headquartered in Seattle, is a technology-enabled provider of certification training and continuing education to healthcare professionals across the Western U.S.; Seaside plans to invest in the platform's technology and pursue complementary service and content acquisitions to drive growth.

  • Buyer
    Pine Tree Equity IV, LP (Pine Tree Equity)
    Target
    Summit Health Pharmacy, LLC
    Seller
    Existing management (partnered with Pine Tree Equity)

    Pine Tree Equity IV, LP recapitalized Summit Health Pharmacy, LLC in December 2021, partnering with the existing management team to support the company's growth. Summit, headquartered in Brookhaven, Pennsylvania and founded in 1995, is a specialty compounding pharmacy focused on rare pediatric metabolic medications; the recapitalization is intended to accelerate geographic expansion and enable complementary add-on acquisitions.

  • Buyer
    Kohlberg & Company
    Target
    Trinity Life Sciences
    Seller
    Parthenon Capital

    Kohlberg & Company will recapitalize Trinity Life Sciences, replacing Parthenon Capital as the company’s capital partner. The transaction provides Trinity with new growth capital to support global expansion, technology and data-driven capability investments while Trinity’s management team, led by CEO David Fitzhenry, will remain in place.

  • Buyer
    WindRose Health Investors, LLC
    Target
    StateServ Medical
    Seller
    Blue Wolf Capital Partners LLC

    WindRose Health Investors completed a recapitalization of StateServ Medical, partnering with the company’s management to provide growth capital and support national expansion. Blue Wolf Capital Partners sold its stake in StateServ following its investment and transformation of the business since 2017; terms were not disclosed.

  • Buyer
    GI Partners, TA Associates
    Target
    Rectangle Health

    GI Partners has completed a recapitalization investment in Rectangle Health alongside existing investor TA Associates. The capital will support Rectangle Health's growth initiatives, product development and M&A strategy as the healthcare payments and patient engagement platform scales its business serving medical, dental and specialty practices.

  • Buyer
    Martis Capital, NaviMed Capital, Lighthouse management team
    Target
    Lighthouse Lab Services

    Martis Capital has made a majority growth recapitalization investment in Lighthouse Lab Services, alongside existing investor NaviMed Capital and the company's management team. Lighthouse, headquartered in Charlotte, North Carolina, provides end-to-end lab build-out, management, staffing, and consulting services to clinical laboratories across the United States; financial terms were not disclosed.

  • Buyer
    Mountain Crest Acquisition Corp II, Farallon Capital Management, RS Investments, Sectoral Asset Management, Monashee Investment Management
    Target
    Better Therapeutics, Inc.

    Mountain Crest Acquisition Corp II completed a business combination with Better Therapeutics, taking the prescription digital therapeutics company public on Nasdaq under the ticker BTTX. The transaction generated approximately $70 million in gross proceeds (including a PIPE led by Farallon Capital Management, RS Investments, Sectoral Asset Management and Monashee Investment Management) and included a contingent credit facility from Hercules Capital to fund clinical development and regulatory efforts for Better Therapeutics' lead product, BT-001.

  • Buyer
    FINVASIA
    Target
    Gini Health
    Seller
    TechStars, Rangle, Uken, Other prior investors
    Location
    Ontario, Canada

    FINVASIA has made an investment in Canada-based digital health company Gini Health, with previous investors exiting and FINVASIA and founder Gurjot Narwal becoming the company’s key stakeholders. The deal positions FINVASIA to expand into preventive and personalized healthcare services while providing Gini Health with capital, operational resources and platform support to accelerate product and market growth.

  • Buyer
    Flourish Research, NMS Capital
    Target
    Excel Medical Clinical Trials, LLC

    NMS Capital portfolio company Flourish Research partnered with Excel Medical Clinical Trials in a recapitalization. The Boca Raton, Florida-based clinical research site, founded by Dr. Seth Baum and focused on cardiology indications, will join Flourish's site network to expand the platform's geographic footprint and therapeutic capabilities; terms were not disclosed and management will remain in place.

  • Buyer
    H.I.G. Capital
    Target
    Health Network One

    H.I.G. Capital completed a recapitalization of Health Network One, a Ft. Lauderdale-based provider of specialty benefit management and provider network services for health insurers. The investment will support platform investment, capability enhancement, and accelerated growth organically and through M&A.

  • Buyer
    Linden Capital Partners
    Target
    BioIVT
    Seller
    Arsenal Capital Partners, BioIVT management team

    Linden Capital Partners has completed a majority recapitalization of BioIVT, a Westbury, New York-based provider of mission-critical biological specimens and value-added services, alongside continuing investor Arsenal Capital Partners and BioIVT management. Financial terms were not disclosed; Linden will support BioIVT’s plans to accelerate organic growth and pursue acquisitions, with debt financing provided by funds managed by Ares Management’s Credit Group and Golub Capital.

  • Buyer
    Parthenon Capital, Blue Venture Fund
    Target
    Smart Data Solutions

    Parthenon Capital completed a recapitalization of Smart Data Solutions (SDS), a provider of payer-focused claims automation, workflow and data management solutions. The Blue Venture Fund, representing 35 Blue Cross Blue Shield plans, also invested to support SDS's growth, product innovation and strategic acquisitions; terms were not disclosed.

  • Buyer
    Mastern Partners
    Target
    Preedlife
    Seller
    VIG Partners
    Location
    Seoul, South Korea

    Mastern Partners, the private equity unit of Mastern Investment Management, has purchased a 10% stake in South Korea's largest funeral services provider Preedlife for about 50 billion won. The minority stake sale to Mastern, together with a recently completed 150 billion won recapitalization, will help diversify Preedlife's investment portfolio into alternative assets and allow VIG Partners to return capital to its limited partners.

  • Buyer
    GHO Capital Partners LLP
    Target
    ClearView Healthcare Partners
    Seller
    RLH Equity Partners, ClearView management (founding partners)

    GHO Capital Partners LLP has acquired a majority ownership position in ClearView Healthcare Partners in a majority recapitalisation from RLH Equity Partners and ClearView management. The investment will support ClearView’s international expansion (particularly into Europe) and the broadening of its life-sciences consulting capabilities, including data analytics and pricing & market access services.

  • Buyer
    Webster Equity Partners
    Target
    Reproductive Gynecology & Infertility (RGI)
    Seller
    RGI legacy/physician shareholders (including David M. Nash, MD; Priya B. Maseelall, MD; Akas Jain, MD)

    Webster Equity Partners completed a majority recapitalization of Reproductive Gynecology & Infertility (RGI), a leading Ohio-based fertility and reproductive medicine practice. The transaction provides liquidity to RGI’s physician shareholders and positions the practice to pursue growth and expansion across its Ohio locations; terms were not disclosed.

  • Buyer
    Vesey Street Capital Partners, LLC
    Target
    Safecor Health

    Funds managed by Vesey Street Capital Partners completed a recapitalization of Safecor Health, the national leader in pharmaceutical unit-dose packaging services for hospitals, health systems, manufacturers and digital pharmacy companies. The recapitalization (terms undisclosed) is intended to support Safecor's growth, investment in capabilities and expansion via add-on acquisitions; JP Morgan provided debt financing.

  • Buyer
    Clearview Capital Fund IV, L.P. (Clearview Capital)
    Target
    LTC Consulting Services, LLC

    Clearview Capital Fund IV, L.P. completed a recapitalization of LTC Consulting Services, LLC on August 9, 2021, partnering with the company's management team. LTC, a Lakewood, New Jersey–based provider of revenue cycle management, finance, accounts payable, credentialing and related office management services to skilled nursing facilities, will continue to be led by co-founders Michael Bauman and Mark Josefovic who retained significant equity.

  • Buyer
    WestView Capital Partners
    Target
    Framework Solutions

    WestView Capital Partners, a Boston-based private equity firm, completed a growth recapitalization investment in Framework Solutions, a Danbury, Connecticut-based provider of outsourced MLR/PRC and regulatory support services for life sciences and pharmaceutical companies. The capital will support Frameworks' growth plans, expand capabilities and resources, and WestView partners Greg Thomas and Thomas Vo will join the company's board.

  • Buyer
    NMS Capital, Flourish Research
    Target
    Clinical Trials of Texas

    NMS Capital formed a new platform, Flourish Research, and completed a recapitalization of Clinical Trials of Texas (CTT) in partnership with founder Kay Scroggins and company management. The deal makes CTT the inaugural partner in a buy-and-build strategy to create a nationwide network of clinical research sites; CTT is headquartered in San Antonio, Texas, operates a 20,000+ sq. ft. facility and has conducted over 1,000 trials across more than 15 therapeutic areas.

  • Buyer
    WestView Capital Partners
    Target
    Kymanox Corporation

    Boston-based private equity firm WestView Capital Partners completed a growth recapitalization investment in Kymanox, a Morrisville, North Carolina life-science professional services company. WestView partners Jonathan Hunnicutt and Jeff Clark will join Kymanox's board as the company looks to expand the depth and breadth of its engineering, scientific, regulatory, and project management service offerings. The transaction included debt financing from Abacus Finance Group and was supported by legal advisors (Latham & Watkins for WestView; Connor Law Group for Kymanox).

  • Buyer
    Great Hill Partners
    Target
    Labor First, LLC

    Great Hill Partners completed a recapitalization of Labor First to support the company's growth and expand its group retiree Medicare benefit management capabilities. The investment will fund expansion of Labor First’s salesforce and broker channels, new product introductions, member advocacy and technology; Great Hill partners will join Labor First’s board. Financial terms were not disclosed.

  • Buyer
    Carousel Capital, Cadrillion Capital
    Target
    Legacy Data Access, LLC

    Carousel Capital has partnered with Cadrillion Capital to recapitalize Legacy Data Access, LLC, a Charlotte-based provider of healthcare data lifecycle management and legacy EHR/EMR archiving solutions. The recapitalization will provide capital to support LDA's growth and platform development, with Carousel funding the transaction from its sixth investment fund.

  • Buyer
    NMS Capital
    Target
    DirectMed Parts & Service, LLC
    Seller
    DirectMed management

    NMS Capital has completed a recapitalization of DirectMed Parts & Service, a San Diego-based provider of medical imaging parts and repair services. The investment will support DirectMed's growth initiatives including acquisitions, expansion into new diagnostic imaging modalities, and enhancement of inventory, engineering and data-driven sales capabilities; terms were not disclosed.

  • Buyer
    H.I.G. Capital
    Target
    Health Network One

    H.I.G. Capital completed a recapitalization of Health Network One (HNO), a Fort Lauderdale-based operator of single-specialty provider networks. Financial terms were not disclosed; the recapitalization is intended to provide HNO with additional resources to support growth and continued network expansion.

  • Buyer
    Cressey & Company LP, Lifeway Mobility Senior Management
    Target
    Lifeway Mobility
    Seller
    Rockwood Equity Partners

    Cressey & Company LP has completed a recapitalization of Lifeway Mobility alongside Lifeway senior management, with Rockwood Equity Partners exiting the investment. Lifeway, a Hartford-based provider of home accessibility equipment and installation services, will use the new capital to accelerate organic growth, pursue add-on acquisitions and expand its regional footprint across the United States.

  • Buyer
    Periscope Equity
    Target
    MAS Medical Staffing LLC
    Seller
    Founder and management team (Ken Johnson)

    Periscope Equity completed a recapitalization of MAS Medical Staffing LLC, partnering with management as the first platform investment from Periscope Equity II. MAS is a tech-enabled medical staffing agency based in New Hampshire that serves long-term care, acute, and home-based care markets via its MAESTRA marketplace platform and will use the partnership to expand geographically, accelerate technology development, and pursue strategic acquisitions.

  • Buyer
    MSouth Equity Partners, Fulcrum Equity Partners
    Target
    Summit Spine & Joint Centers

    Atlanta-based private equity firm MSouth Equity Partners completed the acquisition of Summit Spine & Joint Centers, a Lawrenceville, Georgia operator of ambulatory surgery centers and pain management clinics. The transaction was executed in partnership with Summit's management team and existing sponsor Fulcrum Equity Partners, with financing provided by Audax Private Debt to support MSouth's investment and growth plans across the Southeast.

  • Buyer
    The Vistria Group, LHC Group, Amedisys, Encompass Health
    Target
    Medalogix, Muse Healthcare

    The Vistria Group led a recapitalization and growth investment in Medalogix and Muse Healthcare, consolidating the two data-science and machine-learning businesses under the Medalogix brand to expand clinical decision‑support capabilities for home health, palliative and hospice providers. Minority equity investors in the transaction include LHC Group, Amedisys Home Health and Hospice, and Encompass Health, which will help accelerate adoption across a large nationwide provider footprint.

  • Buyer
    Vistria Fund IV, Apollo Impact Mission (Apollo Global Management)
    Target
    Supplemental Health Care
    Seller
    Vistria Fund, LP (Vistria Fund I), The Vistria Group

    Vistria Fund IV and Apollo Impact Mission (Apollo Global's impact fund) will become equal owners of Supplemental Health Care as The Vistria Group liquidates its prior Fund I holding. The recapitalization creates a strategic partnership to accelerate growth of Supplemental Health Care, a leading healthcare staffing and workforce solutions provider that manages roughly 4,000 clinicians on assignment daily.

  • Buyer
    Nordic Capital
    Target
    United Veterinary Care
    Seller
    Atlantic Street Capital

    Nordic Capital has agreed to invest in United Veterinary Care (UVC), acquiring the shareholdings controlled by Atlantic Street Capital and joining UVC's veterinary owner-practitioners as a major shareholder. UVC is a Palm Beach Gardens, Florida–based multi-location veterinary group operating more than 60 hospitals across 13 U.S. states with over 1,200 employees; the transaction supports the company's continued organic and acquisitive growth.

  • Buyer
    Healthcare Outcomes Performance Company (HOPCo), Audax Private Equity, Linden Capital Partners, Frazier Healthcare Partners
    Target
    Spine Nevada

    Healthcare Outcomes Performance Company (HOPCo), backed by private equity investors Audax Private Equity, Linden Capital Partners and Frazier Healthcare Partners, completed a recapitalization partnership with Spine Nevada. The deal, which closed April 23, 2021, positions Spine Nevada as the HOPCo Nevada care platform to expand musculoskeletal, orthopedic, sports medicine, spine, vein and related services across Nevada.

  • Buyer
    WindRose Health Investors
    Target
    Bluestone Physician Services

    WindRose Health Investors completed an equity recapitalization of Bluestone Physician Services to provide growth capital and support expansion. Bluestone — a provider of on-site primary care, care coordination, and behavioral health services for high-risk, geriatric and disabled patients — will continue to be led by founder Dr. Todd Stivland, who and the executive team retain a significant minority stake.

  • Buyer
    WindRose Health Investors, LLC
    Target
    Veristat Group Inc.
    Seller
    Variance Development Partners

    WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.

  • Buyer
    Clayton, Dubilier & Rice (CD&R), Merck Global Health Innovation Fund (Merck GHI), McKesson Ventures
    Target
    M2GEN

    Clayton, Dubilier & Rice (CD&R) led a recapitalization of oncology data and informatics company M2GEN, with strategic investments from Merck Global Health Innovation Fund and McKesson Ventures. The transaction — which closed with terms undisclosed — positions CD&R as the largest shareholder and will fund growth of M2GEN's linked clinical and genomic data assets and expanded technology and informatics capabilities.

  • Buyer
    Wellspring Capital Management
    Target
    HealthPRO Heritage
    Seller
    BPOC

    Wellspring Capital Management has closed a recapitalization of HealthPRO Heritage, a Hunt Valley, Maryland-based provider of contract therapy and clinical services to post-acute and home health providers. The transaction was a purchase from BPOC; HealthPRO Heritage management retains a significant equity stake and Wellspring plans to support the company's next phase of growth and add-on activity.

  • Buyer
    Pine Tree Equity IV, LP (Pine Tree Equity)
    Target
    Madame Rx, LLC d/b/a Chemistry Rx

    Pine Tree Equity IV, LP recapitalized Madame Rx, LLC d/b/a Chemistry Rx in March 2021, partnering with the founder and management team. The recapitalization will support Chemistry Rx’s geographic expansion and enable pursuit of complementary add-on acquisitions to grow the compounding and specialty pharmacy platform.

  • Buyer
    Cimarron Healthcare Capital
    Target
    CareAccess MSO

    Cimarron Healthcare Capital has completed a recapitalization of CareAccess MSO in partnership with the company's management team to provide capital for the business's next phase of growth. CareAccess is a Los Angeles County–based management services organization that helps independent physician groups establish and manage value-based risk contracts with Medicare Advantage plans; financial terms were not disclosed.

  • Buyer
    Latour Capital
    Target
    Funecap Groupe
    Seller
    Charterhouse Capital Partners LLP
    Location
    Île-de-France, France

    Latour Capital has acquired a minority stake in Funecap Groupe from Charterhouse Capital Partners as a partial realisation of Charterhouse's investment. Charterhouse will retain an interest in Funecap and continue to support the company's next phase of growth alongside management and Latour Capital; Funecap operates a nationwide network of funeral agencies, funeral homes and crematoria in France.

  • Buyer
    SV Health Investors, LLC
    Target
    Health Payment Systems, Inc.
    Seller
    Caltius Equity Partners

    SV Health Investors has completed a recapitalization of Caltius Equity Partners' investment in Health Payment Systems (HPS). The investment will support HPS' expansion in the Upper Midwest and beyond and includes leadership additions with Tom Policelli named CEO and Tom Flynn joining HPS' board.

  • Buyer
    Bridgepoint Development Capital
    Target
    Prescient Healthcare Group
    Seller
    Baird Capital
    Location
    England, United Kingdom

    Bridgepoint Development Capital led a recapitalization of Prescient Healthcare Group, a London-based product strategy consultancy serving the global biopharmaceutical industry; the transaction closed January 19, 2021. Baird Capital (the exiting majority investor) provided a full exit but reinvested as a minority shareholder alongside Bridgepoint to support Prescient's next phase of growth and international expansion.

  • Buyer
    Advent International, Great Hill Partners
    Target
    RxBenefits

    Advent International has completed a recapitalization of RxBenefits alongside existing investor Great Hill Partners, valuing the technology-enabled pharmacy benefits optimizer at approximately $1.1 billion. Advent and Great Hill now each hold equal stakes alongside a significant management investment; the financing will fund expansion of the salesforce, broker channels and technology and support continued organic growth and M&A.

  • Buyer
    Brentwood Associates
    Target
    MedBridge
    Seller
    LLR Partners, Senior management / existing shareholders

    Brentwood Associates has recapitalized MedBridge, a SaaS provider of patient engagement and clinical education solutions, with LLR Partners and senior management retaining significant minority stakes. The investment will fund continued organic growth, support future acquisitions, and enable expansion into additional healthcare specialties and care settings.

  • Buyer
    Clearview Capital Fund IV, L.P.
    Target
    MBI Industrial Medicine, Inc.

    Clearview Capital Fund IV, L.P. recapitalized MBI Industrial Medicine, a Phoenix-based provider of occupational injury care, in a transaction that closed December 18, 2020. The investment — completed in partnership with MBI management — provides capital to support the company's organic growth, acquisition strategy and geographic expansion beyond Arizona.

  • Buyer
    LongueVue Capital, Adrian Otte
    Target
    KPS Life, LLC

    LongueVue Capital partnered with Life Sciences Operating Partner Adrian Otte to provide a structured debt and preferred equity recapitalization and growth investment in KPS Life, LLC, the Malvern, Pennsylvania-based functional service provider (FSP) for clinical trials. The investment is KPS's first institutional capital and will support the company's global expansion and capability development in clinical monitoring, data management, eTMF, and medical writing.

  • Buyer
    Main Street Capital Corporation
    Target
    Northeast Nebraska Vet Services, PC, Heritage Animal Health, LLC
    Seller
    Existing owners and senior management

    Main Street Capital Corporation provided $17.0 million of debt and a minority equity investment to facilitate a minority recapitalization of Northeast Nebraska Vet Services, PC (NVS) and Heritage Animal Health, supporting the companies’ growth and acquisition strategy. Bridgepoint Investment Banking acted as exclusive financial advisor to the companies on the transaction.

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.

Related Acquisition Pages